Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bonus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

8 resultados carregados na pagina 5 para "drug"
‘Danger no longer only comes from the hitmen, but from the state’: the Honduran farmers la
‘Danger no longer only comes from the hitmen, but from the state’: the Honduran farmers la
After another massacre of smallholders – who are subjected to violence from palm oil firms and drug traffickers – the country’s new Trump-backed government has criminalised community leadersSitting on the back of the motorcycle, 15-year-old Orlean* heard gunshots. A moment later,
Charge-based strategy improves controlled delivery of therapeutic peptides from gelatin-ba
Charge-based strategy improves controlled delivery of therapeutic peptides from gelatin-ba
Rice University engineers have developed a new strategy for controlling how therapeutic peptides are released from gelatin-based materials, a step that could make the small but powerful molecules more useful in tissue engineering and drug delivery.
FDA approves first drug for full range of narcolepsy symptoms
FDA approves first drug for full range of narcolepsy symptoms
The U.S. Food and Drug Administration has approved Orzeyful (oveporexton) tablets to treat narcolepsy type 1 in adults. Orzeyful marks the first medication approved for the full range of symptoms associated with narcolepsy type 1 and is the first approved drug to directly target
Atomic view of Alzheimer's disease peptide could inform new drugs
Atomic view of Alzheimer's disease peptide could inform new drugs
One of the hallmarks of Alzheimer's disease is the accumulation of a peptide in the brain known as amyloid beta. A new study published in Nature Communications on July 22 has uncovered the atomic structure of the peptide in its harmful form. Mais do que repetir a manchete, o pont
Foto: Haberdoedas Photography / Pexels
GLP-1 drug linked to heart benefits for high-risk patients
Adding the GLP-1 receptor agonist drug tirzepatide (marketed as Mounjaro) to standard care for patients with type 2 diabetes and heart disease is associated with a lower risk of a major cardiovascular event, such as a heart attack or stroke, finds a study published by The BMJ tod
Foto: Jonathan Borba / Pexels
Dicas
Fitness influencers linked to wellness brand helping run illegal steroid market on Telegram
Ambassadors for Gencore Global directed followers to Telegram channels promoting steroids, prescription medicines and experimental peptides‘I felt dizzy’: body builder recalls how drug abuse caught up with himUK becoming ‘wild west’ for experimental peptides, expert warnsFitness influencers who publicly represent a global wellness brand are involved in running an illegal steroid market on social media, the Guardian can reveal.Gencore Global presents itself as a UK-based health and well
Foto: Gustavo Fring / Pexels
Dicas
‘A new consumer’: how weight-loss drugs are shaking up clothes shopping
As they slim down, UK and US users of GLP-1 jabs and pills are changing their spending habits – and their wardrobesTell us: what does the new weight-loss pill mean for you?“I’m now at a point where I’m going to buy even more clothes,” says Hayley Grice, 50, from Shropshire, who has dropped seven sizes after starting on the GLP-1 weight loss jab Mounjaro two years ago. “I’m very happy with my physique right now.”Grice, the financial director of a business she set up with her husband, tr
Foto: Mitchell Henderson / Pexels
Dicas
UK housing market downturn eases but sentiment remains ‘fragile’, surveyors say – business live
Brent crude dips slightly below $78 a barrel; most Asian stock markets bounce backBritain’s second-biggest drugmaker GSK has also taken a hit from recent drug failures.The Californian biotech Alector has said that GSK has ended their neuroscience collaboration covering ​two experimental antibody drugs, after both drug candidates suffered setbacks in clinical trials.The CARDIO-TTRansform trial was designed to examine the role of Wainua, a gene silencer treatment, on top of today’s stand